Published data demonstrates the effects of PL8331 in mouse models of retinal disease
April 19th 2023Palatin Technologies, Inc. announced manuscript publication that summarizes data demonstrating the effects of PL8331 in two mouse models of retinal disease, experimental autoimmune uveoretinitis and diabetic retinopathy.
Read More